<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical evidence. Some small studies demonstrate clinical benefits in asthma patients. In a randomized, double-blind, placebo-controlled trial supplementation of standard therapy with soft gel capsules of cold-pressed 
 <italic>N. sativa</italic> oil (0.7% thymoquinone) improved asthma control with a trend in pulmonary function improvement. Two of the five subscores (impact of asthma on work, school, or at home and shortness of breath and the overall score) showed a significant improvement. The other three were not significantly improved. At the same time, a remarkable normalization of blood eosinophilia count was observed (
 <xref rid="B277" ref-type="bibr">Koshak et al., 2017</xref>). The release of IL-2, IL-6, and PGE2 in T-lymphocytes, as well as IL-6 and PGE2 in monocytes, were suppressed. Overall, the clinical evidence is Medium for asthma.
</p>
